TVM Capital Life Science (TVM), a leading international venture capital firm focused on investments in life sciences innovation, announced an investment of up to $25 million in the newly formed U.S.-based biotechnology company, LAmAb Biologics (LAmAb), with its fund TVM Life Science Innovation II SCSp (TVM LSI II).
TVM Capital Healthcare, an emerging-markets focused healthcare private equity firm headquartered in Singapore and Dubai, with presence in Boston and Munich, and Siemens Healthineers, have announced a landmark cooperation to support and accelerate the growth of innovative healthcare companies in Southeast Asia (SEA).